{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:08:43Z","timestamp":1778785723243,"version":"3.51.4"},"reference-count":125,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/tp.0000000000000922","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T12:13:53Z","timestamp":1444306433000},"page":"515-524","source":"Crossref","is-referenced-by-count":40,"title":["Autoimmune Liver Disease Post-Liver Transplantation"],"prefix":"10.1097","volume":"100","author":[{"given":"Catherine","family":"Edmunds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udeme D.","family":"Ekong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation.","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation.","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.","volume":"78","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Transplantation"},{"key":"R4-15-20210129","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institutions experience.","volume":"43","author":"Cho","year":"2011","journal-title":"Transplant Proc"},{"key":"R5-15-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005176-200102000-00007","article-title":"Autoimmune hepatitis as a late complication of liver transplantation.","volume":"32","author":"Hernandez","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R6-15-20210129","first-page":"702","article-title":"What is the long-term outcome of the liver allograft J Hepatol.","volume":"55","author":"Hubscher","year":"2011","journal-title":""},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis.","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MPG.0b013e3181a1c265","article-title":"Autoimmune hepatitis.","volume":"49","author":"Mieli-Vergani","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R9-15-20210129","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.","volume":"7","author":"Venick","year":"2007","journal-title":"Am J Transplant"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.21280","article-title":"Liver biopsy interpretation for causes of late liver allograft dysfunction.","volume":"44","author":"Banff Working Group, Demetris","year":"2006","journal-title":"Hepatology"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"R12-15-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases.","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R13-15-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation.","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"R14-15-20210129","first-page":"237","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis Gut.","volume":"56","author":"Berardi","year":"2007","journal-title":""},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.dld.2014.03.002","article-title":"De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency.","volume":"46","author":"Aguilera","year":"2014","journal-title":"Dig Liver Dis"},{"key":"R16-15-20210129","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"R17-15-20210129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gutjnl-2011-300708","article-title":"Chronic hepatitis E infection in children with liver transplantation.","volume":"61","author":"Halac","year":"2012","journal-title":"Gut"},{"key":"R18-15-20210129","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2249.2001.01682.x","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation.","volume":"126","author":"Aguilera","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R19-15-20210129","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/lt.20209","article-title":"Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation.","volume":"10","author":"Aguilera","year":"2004","journal-title":"Liver Transpl"},{"key":"R20-15-20210129","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/01.tp.0000259963.47350.da","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation.","volume":"83","author":"Rodriguez-Mahou","year":"2007","journal-title":"Transplantation"},{"key":"R21-15-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/0929867306666220208213032","article-title":"Glutathione S-transferasesa review.","volume":"6","author":"Salinas","year":"1999","journal-title":"Curr Med Chem"},{"key":"R22-15-20210129","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1016\/j.transproceed.2005.10.042","article-title":"Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation.","volume":"37","author":"Aguilera","year":"2005","journal-title":"Transplant Proc"},{"key":"R23-15-20210129","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis.","volume":"17","author":"Aguilera","year":"2011","journal-title":"Liver Transpl"},{"key":"R24-15-20210129","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1681\/ASN.V10102208","article-title":"Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.","volume":"10","author":"Collins","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R25-15-20210129","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/01.ASN.0000025780.03790.0F","article-title":"Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.","volume":"13","author":"Regele","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R26-15-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.TP.0000148987.13199.10","article-title":"Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection.","volume":"79","author":"Poduval","year":"2005","journal-title":"Transplantation"},{"key":"R27-15-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: Contrasts and comparisons in children and adultsa comprehensive review.","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun"},{"key":"R28-15-20210129","first-page":"783","article-title":"Autoimmune liver diseases in childrenwhat is different from adulthood Best Pract Res Clin Gastroenterol.","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":""},{"key":"R29-15-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1522162802239754","article-title":"Overlap between alloimmunity and autoimmunity in the rat and human: evidence for important contributions for dendritic and regulatory.","volume":"6","author":"Demetris","year":"2003","journal-title":"Cells Graft"},{"key":"R30-15-20210129","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI1117","article-title":"Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.","volume":"101","author":"Ciubotariu","year":"1998","journal-title":"J Clin Invest"},{"key":"R31-15-20210129","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","article-title":"Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R32-15-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1399-0012.2007.00667.x","article-title":"Clinical relevance of autoantibodies after pediatric liver transplantation.","volume":"21","author":"Richter","year":"2007","journal-title":"Clin Transplant"},{"key":"R33-15-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/MPG.0b013e31805ce219","article-title":"Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation.","volume":"45","author":"Avitzur","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R34-15-20210129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis.","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"R35-15-20210129","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1111\/j.1872-034X.2007.00287.x","article-title":"De novo autoimmune hepatitis after liver transplantation.","volume":"37","author":"Lohse","year":"2007","journal-title":"Hepatol Res"},{"key":"R36-15-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1196\/annals.1398.041","article-title":"Identification by proteomic tool of atypical anti-liverkidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantation.","volume":"1109","author":"Huguet","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R37-15-20210129","doi-asserted-by":"crossref","first-page":"413928","DOI":"10.1155\/2013\/413928","article-title":"Induction of antinuclear antibodies by de novo autoimmune hepatitis regulates alloimmune responses in rat liver transplantation.","volume":"2013","author":"Nakano","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R38-15-20210129","first-page":"113","article-title":"Autoimmune hepatitis.","volume":"50","author":"Vergani","year":"2004","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R39-15-20210129","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/TP.0b013e31829eda7f","article-title":"Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults.","volume":"96","author":"Sebagh","year":"2013","journal-title":"Transplantation"},{"key":"R40-15-20210129","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/ajt.12413","article-title":"Plasma cell hepatitis in liver allografts: identification and characterization of an IgG4-rich cohort.","volume":"13","author":"Castillo-Rama","year":"2013","journal-title":"Am J Transplant"},{"key":"R41-15-20210129","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.transproceed.2012.02.049","article-title":"Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.","volume":"45","author":"Zhao","year":"2013","journal-title":"Transplant Proc"},{"key":"R42-15-20210129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/lt.20673","article-title":"Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience.","volume":"12","author":"Riva","year":"2006","journal-title":"Liver Transpl"},{"key":"R43-15-20210129","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation.","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"R44-15-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation.","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"R45-15-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease.","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"R47-15-20210129","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation.","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"R48-15-20210129","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation.","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl"},{"key":"R50-15-20210129","first-page":"1300","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process Transplantation.","volume":"66","author":"Jeyarajah","year":"1998","journal-title":""},{"key":"R51-15-20210129","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation.","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"R52-15-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R53-15-20210129","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"R54-15-20210129","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"R55-15-20210129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"key":"R56-15-20210129","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"R57-15-20210129","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"R58-15-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity.","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl"},{"key":"R59-15-20210129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation.","volume":"13","author":"Carbone","year":"2013","journal-title":"Am J Transplant"},{"key":"R60-15-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"R61-15-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transpl"},{"key":"R62-15-20210129","first-page":"16","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantationthe Hungarian experience.","volume":"6","author":"Gelley","year":"2014","journal-title":"Interv Med Appl Sci"},{"key":"R63-15-20210129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/lt.23868","article-title":"Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.","volume":"20","author":"Venkat","year":"2014","journal-title":"Liver Transpl"},{"key":"R64-15-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/lt.22320","article-title":"Studies of Pediatric Liver Transplantation Research Group. Pediatric liver transplantation for primary sclerosing cholangitis.","volume":"17","author":"Miloh","year":"2011","journal-title":"Liver Transpl"},{"key":"R65-15-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantationa single-centre experience.","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"R66-15-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"issue":"Suppl 3","key":"R67-15-20210129","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1111\/j.1872-034X.2007.00245.x","article-title":"Histological recurrence of autoimmune liver diseases after living-donor liver transplantation.","volume":"37","author":"Haga","year":"2007","journal-title":"Hepatol Res"},{"key":"R68-15-20210129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1478-3231.2006.01395.x","article-title":"Recurrence of primary sclerosing cholangitis after living donor liver transplantation.","volume":"27","author":"Tamura","year":"2007","journal-title":"Liver Int"},{"key":"R69-15-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"R70-15-20210129","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum Pathol"},{"key":"R71-15-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"key":"R72-15-20210129","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"key":"R73-15-20210129","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl"},{"key":"R74-15-20210129","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1478-3231.2010.02422.x","article-title":"The combination of primary sclerosing cholangitis and CCR5-[INCREMENT]32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.","volume":"31","author":"op den Dries","year":"2011","journal-title":"Liver Int"},{"key":"R75-15-20210129","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2353\/ajpath.2010.090759","article-title":"CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.","volume":"176","author":"Dobaczewski","year":"2010","journal-title":"Am J Pathol"},{"key":"R76-15-20210129","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/j.1600-6143.2009.02786.x","article-title":"CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.","volume":"9","author":"Nozaki","year":"2009","journal-title":"Am J Transplant"},{"key":"R77-15-20210129","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2005-04-1632","article-title":"Critical role for CCR5 in the function of donor CD4CD25 regulatory T cells during acute graft-versus-host disease.","volume":"106","author":"Wysocki","year":"2005","journal-title":"Blood"},{"key":"R78-15-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.med.50.1.425","article-title":"Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS.","volume":"50","author":"Locati","year":"1999","journal-title":"Annu Rev Med"},{"key":"R79-15-20210129","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2353\/ajpath.2007.060690","article-title":"CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.","volume":"170","author":"Ajuebor","year":"2007","journal-title":"Am J Pathol"},{"key":"R80-15-20210129","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)65068-7","article-title":"Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.","volume":"156","author":"Dawson","year":"2000","journal-title":"Am J Pathol"},{"issue":"Pt 3","key":"R81-15-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1099\/vir.0.81339-0","article-title":"Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1.","volume":"87","author":"Carr","year":"2006","journal-title":"J Gen Virol"},{"key":"R82-15-20210129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1478-3231.2011.02459.x","article-title":"Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation.","volume":"31","author":"Ten Hove","year":"2011","journal-title":"Liver Int"},{"key":"R83-15-20210129","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry.","volume":"11","author":"Egawa","year":"2011","journal-title":"Am J Transplant"},{"key":"R84-15-20210129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence.","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"issue":"Suppl 2","key":"R85-15-20210129","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transpl"},{"key":"R86-15-20210129","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"key":"R87-15-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis.","volume":"34","author":"Longhi","year":"2010","journal-title":"J Autoimmun"},{"key":"R88-15-20210129","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a single-center experience.","volume":"39","author":"Khalaf","year":"2007","journal-title":"Transplant Proc"},{"key":"R89-15-20210129","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1600-6143.2010.03080.x","article-title":"Phenotypic expression of recurrent disease after liver transplantation.","volume":"10","author":"OGrady","year":"2010","journal-title":"Am J Transplant"},{"key":"R90-15-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center.","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"R91-15-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinre.2011.02.007","article-title":"Liver transplantation in PBC and PSC: indications and disease recurrence.","volume":"35","author":"Carbone","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R92-15-20210129","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history.","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"key":"R93-15-20210129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181622490","article-title":"Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.","volume":"32","author":"Abraham","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R94-15-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","article-title":"Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation.","volume":"20","author":"Klein","year":"1994","journal-title":"J Hepatol"},{"key":"R95-15-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.182.1.309","article-title":"Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.","volume":"182","author":"Fukami","year":"2009","journal-title":"J Immunol"},{"key":"R96-15-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming.","volume":"8","author":"Dong","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R97-15-20210129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat.","volume":"9","author":"Manel","year":"2008","journal-title":"Nat Immunol"},{"key":"R98-15-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3 CD25 CD4 natural regulatory T cells in dominant self-tolerance and autoimmune disease.","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"R99-15-20210129","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4CD25 regulatory T cells in patients with multiple sclerosis.","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"R100-15-20210129","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","article-title":"Phenotypic and functional analysis of CD4 CD25 Foxp3 T cells in patients with systemic lupus erythematosus.","volume":"182","author":"Bonelli","year":"2009","journal-title":"J Immunol"},{"key":"R101-15-20210129","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.22699","article-title":"Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.","volume":"56","author":"Franz","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R102-15-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.","volume":"35","author":"Scheinecker","year":"2010","journal-title":"J Autoimmun"},{"key":"R103-15-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J Immunol"},{"key":"R104-15-20210129","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/ken108","article-title":"Altered frequency and migration capacity of CD4CD25 regulatory T cells in systemic lupus erythematosus.","volume":"47","author":"Lee","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R105-15-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/0961203307080226","article-title":"Measurement of natural (CD4CD25high) and inducible (CD4IL-10) regulatory T cells in patients with systemic lupus erythematosus.","volume":"16","author":"Barath","year":"2007","journal-title":"Lupus"},{"key":"R106-15-20210129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08916930701610028","article-title":"The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4CD25(high)FoxP3 regulatory T cells during repeated plasmapheresis treatments of patients.","volume":"40","author":"Barath","year":"2007","journal-title":"Autoimmunity"},{"key":"R107-15-20210129","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","article-title":"Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).","volume":"20","author":"Bonelli","year":"2008","journal-title":"Int Immunol"},{"key":"R108-15-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/immu.200390024","article-title":"Isolation and functional characterization of regulatory CD25brightCD4 T cells from the target organ of patients with rheumatoid arthritis.","volume":"33","author":"Cao","year":"2003","journal-title":"Eur J Immunol"},{"key":"R109-15-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4()CD25() regulatory T-cells in autoimmune liver disease.","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"R110-15-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-3046.2012.01648.x","article-title":"Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.","volume":"16","author":"Ekong","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R111-15-20210129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2362.2007.01882.x","article-title":"The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.","volume":"37","author":"Lin","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R112-15-20210129","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/ard.2005.049924","article-title":"Enrichment of CD4 CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.","volume":"65","author":"Suarez","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R113-15-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3 regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol"},{"key":"R114-15-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity.","volume":"41","author":"Lu","year":"2013","journal-title":"J Autoimmun"},{"key":"R115-15-20210129","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells.","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol"},{"key":"R116-15-20210129","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3() conventional T cells.","volume":"37","author":"Baron","year":"2007","journal-title":"Eur J Immunol"},{"key":"R117-15-20210129","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.00144-13","article-title":"Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.","volume":"33","author":"Wang","year":"2013","journal-title":"Mol Cell Biol"},{"key":"R118-15-20210129","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4049\/jimmunol.169.3.1542","article-title":"Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection.","volume":"169","author":"Haque","year":"2002","journal-title":"J Immunol"},{"key":"R119-15-20210129","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-200202270-00002","article-title":"Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance.","volume":"73","author":"Yasufuku","year":"2002","journal-title":"Transplantation"},{"key":"R120-15-20210129","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K- 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant"},{"key":"R121-15-20210129","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI28031","article-title":"IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.","volume":"117","author":"Burlingham","year":"2007","journal-title":"J Clin Invest"},{"key":"R122-15-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2249.2011.04486.x","article-title":"A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.","volume":"167","author":"Tiriveedhi","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R123-15-20210129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.athoracsur.2010.06.009","article-title":"Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.","volume":"90","author":"Bharat","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"R124-15-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1432-2277.2009.00884.x","article-title":"Role of NK and NKT cells in solid organ transplantation.","volume":"22","author":"Pratschke","year":"2009","journal-title":"Transpl Int"},{"key":"R125-15-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-065X.2003.00006.x","article-title":"On the role of self-recognition in T cell responses to foreign antigen.","volume":"191","author":"Stefanova","year":"2003","journal-title":"Immunol Rev"},{"key":"R126-15-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1399-0039.2007.00834.x","article-title":"Allorecognition and the alloresponse: clinical implications.","volume":"69","author":"Afzali","year":"2007","journal-title":"Tissue Antigens"},{"key":"R127-15-20210129","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOT.0b013e328309ee31","article-title":"Pathways of major histocompatibility complex allorecognition.","volume":"13","author":"Afzali","year":"2008","journal-title":"Curr Opin Organ Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T21:36:45Z","timestamp":1653255405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201603000-00015"}},"subtitle":["A Summary and Proposed Areas for Future Research"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000922","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}